List of Excipients in API CAPIVASERTIB
✉ Email this page to a colleague
Excipients in NDA-approved (novel) drugs containing CAPIVASERTIB
Company | Tradename | Ingredient | NDC | Excipient | Potential Generic Entry |
---|---|---|---|---|---|
AstraZeneca Pharmaceuticals LP | TRUQAP | capivasertib | 0310-9500 | ANHYDROUS DIBASIC CALCIUM PHOSPHATE | 2028-11-16 |
AstraZeneca Pharmaceuticals LP | TRUQAP | capivasertib | 0310-9500 | CELLULOSE, MICROCRYSTALLINE | 2028-11-16 |
AstraZeneca Pharmaceuticals LP | TRUQAP | capivasertib | 0310-9500 | COPOVIDONE K25-31 | 2028-11-16 |
AstraZeneca Pharmaceuticals LP | TRUQAP | capivasertib | 0310-9500 | CROSCARMELLOSE SODIUM | 2028-11-16 |
AstraZeneca Pharmaceuticals LP | TRUQAP | capivasertib | 0310-9500 | FERRIC OXIDE RED | 2028-11-16 |
AstraZeneca Pharmaceuticals LP | TRUQAP | capivasertib | 0310-9500 | FERRIC OXIDE YELLOW | 2028-11-16 |
>Company | >Tradename | >Ingredient | >NDC | >Excipient | >Potential Generic Entry |
Detailed excipient profiles for CAPIVASERTIB
Excipient focus: ANHYDROUS DIBASIC CALCIUM PHOSPHATE
CAPIVASERTIB drug variants containing ANHYDROUS DIBASIC CALCIUM PHOSPHATE
Company | Ingredient | NDC |
---|---|---|
AstraZeneca Pharmaceuticals LP | capivasertib | 0310-9500 |
>Company | >Ingredient | >NDC |
CAPIVASERTIB drug variants not containing ANHYDROUS DIBASIC CALCIUM PHOSPHATE
Company | Ingredient | NDC |
---|---|---|
>Company | >Ingredient | >NDC |
Excipient focus: CELLULOSE, MICROCRYSTALLINE
CAPIVASERTIB drug variants containing CELLULOSE, MICROCRYSTALLINE
Company | Ingredient | NDC |
---|---|---|
AstraZeneca Pharmaceuticals LP | capivasertib | 0310-9500 |
>Company | >Ingredient | >NDC |
CAPIVASERTIB drug variants not containing CELLULOSE, MICROCRYSTALLINE
Company | Ingredient | NDC |
---|---|---|
>Company | >Ingredient | >NDC |
Excipient focus: COPOVIDONE K25-31
CAPIVASERTIB drug variants containing COPOVIDONE K25-31
Company | Ingredient | NDC |
---|---|---|
AstraZeneca Pharmaceuticals LP | capivasertib | 0310-9500 |
>Company | >Ingredient | >NDC |
CAPIVASERTIB drug variants not containing COPOVIDONE K25-31
Company | Ingredient | NDC |
---|---|---|
>Company | >Ingredient | >NDC |
Excipient focus: CROSCARMELLOSE SODIUM
CAPIVASERTIB drug variants containing CROSCARMELLOSE SODIUM
Company | Ingredient | NDC |
---|---|---|
AstraZeneca Pharmaceuticals LP | capivasertib | 0310-9500 |
>Company | >Ingredient | >NDC |
CAPIVASERTIB drug variants not containing CROSCARMELLOSE SODIUM
Company | Ingredient | NDC |
---|---|---|
>Company | >Ingredient | >NDC |
Excipient focus: FERRIC OXIDE RED
CAPIVASERTIB drug variants containing FERRIC OXIDE RED
Company | Ingredient | NDC |
---|---|---|
AstraZeneca Pharmaceuticals LP | capivasertib | 0310-9500 |
>Company | >Ingredient | >NDC |
CAPIVASERTIB drug variants not containing FERRIC OXIDE RED
Company | Ingredient | NDC |
---|---|---|
>Company | >Ingredient | >NDC |
Excipient focus: FERRIC OXIDE YELLOW
CAPIVASERTIB drug variants containing FERRIC OXIDE YELLOW
Company | Ingredient | NDC |
---|---|---|
AstraZeneca Pharmaceuticals LP | capivasertib | 0310-9500 |
>Company | >Ingredient | >NDC |
CAPIVASERTIB drug variants not containing FERRIC OXIDE YELLOW
Company | Ingredient | NDC |
---|---|---|
>Company | >Ingredient | >NDC |
Excipient focus: FERROSOFERRIC OXIDE
CAPIVASERTIB drug variants containing FERROSOFERRIC OXIDE
Company | Ingredient | NDC |
---|---|---|
AstraZeneca Pharmaceuticals LP | capivasertib | 0310-9500 |
>Company | >Ingredient | >NDC |
CAPIVASERTIB drug variants not containing FERROSOFERRIC OXIDE
Company | Ingredient | NDC |
---|---|---|
>Company | >Ingredient | >NDC |
Excipient focus: HYPROMELLOSE
CAPIVASERTIB drug variants containing HYPROMELLOSE
Company | Ingredient | NDC |
---|---|---|
AstraZeneca Pharmaceuticals LP | capivasertib | 0310-9500 |
>Company | >Ingredient | >NDC |
CAPIVASERTIB drug variants not containing HYPROMELLOSE
Company | Ingredient | NDC |
---|---|---|
>Company | >Ingredient | >NDC |
Excipient focus: MAGNESIUM STEARATE
CAPIVASERTIB drug variants containing MAGNESIUM STEARATE
Company | Ingredient | NDC |
---|---|---|
AstraZeneca Pharmaceuticals LP | capivasertib | 0310-9500 |
>Company | >Ingredient | >NDC |
CAPIVASERTIB drug variants not containing MAGNESIUM STEARATE
Company | Ingredient | NDC |
---|---|---|
>Company | >Ingredient | >NDC |
Excipient focus: MEDIUM-CHAIN TRIGLYCERIDES
CAPIVASERTIB drug variants containing MEDIUM-CHAIN TRIGLYCERIDES
Company | Ingredient | NDC |
---|---|---|
AstraZeneca Pharmaceuticals LP | capivasertib | 0310-9500 |
>Company | >Ingredient | >NDC |
CAPIVASERTIB drug variants not containing MEDIUM-CHAIN TRIGLYCERIDES
Company | Ingredient | NDC |
---|---|---|
>Company | >Ingredient | >NDC |
Excipient focus: POLYDEXTROSE
CAPIVASERTIB drug variants containing POLYDEXTROSE
Company | Ingredient | NDC |
---|---|---|
AstraZeneca Pharmaceuticals LP | capivasertib | 0310-9500 |
>Company | >Ingredient | >NDC |
CAPIVASERTIB drug variants not containing POLYDEXTROSE
Company | Ingredient | NDC |
---|---|---|
>Company | >Ingredient | >NDC |
Excipient focus: POLYETHYLENE GLYCOL 3350
CAPIVASERTIB drug variants containing POLYETHYLENE GLYCOL 3350
Company | Ingredient | NDC |
---|---|---|
AstraZeneca Pharmaceuticals LP | capivasertib | 0310-9500 |
>Company | >Ingredient | >NDC |
CAPIVASERTIB drug variants not containing POLYETHYLENE GLYCOL 3350
Company | Ingredient | NDC |
---|---|---|
>Company | >Ingredient | >NDC |
Excipient focus: TITANIUM DIOXIDE
CAPIVASERTIB drug variants containing TITANIUM DIOXIDE
Company | Ingredient | NDC |
---|---|---|
AstraZeneca Pharmaceuticals LP | capivasertib | 0310-9500 |
>Company | >Ingredient | >NDC |
CAPIVASERTIB drug variants not containing TITANIUM DIOXIDE
Company | Ingredient | NDC |
---|---|---|
>Company | >Ingredient | >NDC |
Excipient focus: WATER
CAPIVASERTIB drug variants containing WATER
Company | Ingredient | NDC |
---|---|---|
AstraZeneca Pharmaceuticals LP | capivasertib | 0310-9500 |
>Company | >Ingredient | >NDC |
CAPIVASERTIB drug variants not containing WATER
Company | Ingredient | NDC |
---|---|---|
>Company | >Ingredient | >NDC |
Make Better Decisions: Try a trial or see plans & pricing
Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.